Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zhai

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation]R L Zhang, X H Zheng, L K Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 18, 2020
[Clinical features and risk factors analyses of patients with T cell large granular lymphocytosis following allo-HSCT]F Zhao, Y Y Shi, G X Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|January 23, 2025
[Short-term efficacy of rituximab in children with calcineurin inhibitor resistant steroid resistant nephrotic syndrome]S S Yu, J L Liu, J J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Outcomes and prognostic factors of myelodysplastic syndrome patients with allogeneic hematopoietic stem cell transplantation]Z X Liu, M N Lyu, Q Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation]D Feng, M Y Wang, J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]X H Su, J F Yao, G X Zhang, et al.
Neurology|November 23, 2000
Novel mutations in spastin gene and absence of correlation with age at onset of symptomsA Hentati, H X Deng, H Zhai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2025
[Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation]D Feng, W Liang, J X Cao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 30, 2018
[Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation]W H Zhai, Q Z Liu, Y Y Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 2, 2025
[Clinical characteristics and prognostic analysis of carbapenem-resistant Enterobacteriaceae bloodstream infections in patients with hematologic diseases]L N Zhang, Y Q Cui, Q S Lin, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation]R L Zhang, X H Zheng, L K Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 18, 2020
[Clinical features and risk factors analyses of patients with T cell large granular lymphocytosis following allo-HSCT]F Zhao, Y Y Shi, G X Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|January 23, 2025
[Short-term efficacy of rituximab in children with calcineurin inhibitor resistant steroid resistant nephrotic syndrome]S S Yu, J L Liu, J J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Outcomes and prognostic factors of myelodysplastic syndrome patients with allogeneic hematopoietic stem cell transplantation]Z X Liu, M N Lyu, Q Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation]D Feng, M Y Wang, J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]X H Su, J F Yao, G X Zhang, et al.
Neurology|November 23, 2000
Novel mutations in spastin gene and absence of correlation with age at onset of symptomsA Hentati, H X Deng, H Zhai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2025
[Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation]D Feng, W Liang, J X Cao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 30, 2018
[Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation]W H Zhai, Q Z Liu, Y Y Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 2, 2025
[Clinical characteristics and prognostic analysis of carbapenem-resistant Enterobacteriaceae bloodstream infections in patients with hematologic diseases]L N Zhang, Y Q Cui, Q S Lin, et al.
Pageof 18